Find another Doctor or Researcher

A photo of David Haslam.
High Res

David B. Haslam, MD

Director, Antimicrobial Stewardship Program

Academic Affiliations

Associate Professor, UC Department of Pediatrics

Phone 513-803-1170

Email david.haslam@cchmc.org

Specialties
Hide
Pediatric infectious diseases; host-microbial interactions; innate immunity
Education and Training
Hide

MD: University of Calgary, Calgary, Alberta, 1987.

Rotating Internship: McGill University, Montreal, Quebec, 1988.

Residency: University of Ottawa, Ottawa, Quebec, 1991.

Fellowship: Washington University School of Medicine, St. Louis, MO, 2005.

Certification: Pediatric Infectious Diseases, 1997.

Publications
Hide

View PubMed Publications

Cox JW, Ballweg RA, Taft DH, Velayutham P, Haslam DB, Porollo A. A fast and robust protocol for metataxonomic analysis using RNAseq data. Microbiome. 2017 Jan 19;5(1):7. 

Andersen HM, Connolly NV, Bangar H, Staat M, Mortensen J, Deburger B, Haslam DB. Use of Shotgun Metagenome Sequencing to Detect Fecal Colonization with Multi-Drug Resistant Bacteria. J Clin Microbiol. 2016;54:1804-1813.

Zhou Y, Wylie KM, El Feghaly RE, Mihindukulasuriya KA, Elward A, Haslam DB, Storch GA, Weinstock GM. Metagenomic Approach for Identification of the Pathogens Associated with Diarrhea in Stool Specimens. J Clin Microbiol. 2016;54:368-375.

Haslam DB. Nonalcoholic steatohepatitis and the intestinal microbiota. Hepatology. 2016.

Forster CS, Courter J, Jackson EC, Mortensen JE, Haslam DB. Frequency of Multidrug-Resistant Organisms Cultured From Urine of Children Undergoing Clean Intermittent Catheterization. Journal of the Pediatric Infectious Diseases Society. 2016:piw056.

Goldstein SL, Mottes T, Simpson K, Barclay C, Muething S, Haslam DB, Kirkendall ES. A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int. 2016;90:212-221.

Ciricillo J, Haslam D, Blum S, Kim M-O, Liu C, Paulsen G, Courter J, Danziger-Isakov L. Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review. Transpl Infect Dis. 2016 Oct;18(5):706-713.

Dandoy CE, Haslam D, Lane A, Jodele S, Demmel K, El-Bietar J, Flesch L, Myers KC, Pate A, Rotz S, et al. Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016.

El Feghaly R, Stauber J, Tarr PI, Haslam DB. Intestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections. J Pediatr. 2013 Dec;163(6):1697-1704.

El Feghaly R, Stauber J, Deych E, Gonzales C, Tarr PI, Haslam DB. Markers of intestinal Inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin Infect Dis. 2013;56(12):1713-21.

Grants
Hide

Shotgun metagenomic sequencing to detect colonization, invasion, and transmission of multidrug-resistant organisms. Principal Investigator. Centers for Disease Control and Prevention.

Fecal metagenomics as a tool to identify and mitigate risk of bloodstream infection in high risk children. Principal Investigator. Center for Pediatric Genomics, Cincinnati Children’s Hospital Medical Center. Jan 2016-Dec 2016.

Related Professionals

Donate to Cincinnati Children's.

3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462

New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479

© 1999-2018 Cincinnati Children's Hospital Medical Center. All rights reserved.

Visit the U.S. News website. Best Places to Work Logo